35405096 34414429 34528668 36577494 37347728 35389754 36596896 35659433 35044379 37191284 35271802 35507502 36304153 37408070 33723436 35484263 36787187 37508557 34097921 37545642 35074252 35194180 36184080 36116789 34502180 34236487 - Search Results

Year	Number of Results
2021	5
2022	14
2023	11

1

Protein phosphatase 2A regulates cytotoxicity and drug resistance by dephosphorylating AHR and MDR1.

Chen L, Guo P, Li W, Jiang X, Zhao Q, Li D, Wang Q, Xiao Y, Xing X, Pang Y, Aschner M, Zhang L, Chen W. Chen L, et al. J Biol Chem. 2022 May;298(5):101918. doi: 10.1016/j.jbc.2022.101918. Epub 2022 Apr 8. J Biol Chem. 2022. PMID: 35405096 Free PMC article.

2

Colon cancer checks in when bile acids check out: the bile acid-nuclear receptor axis in colon cancer.

Tang Q, Evans RM. Tang Q, et al. Essays Biochem. 2021 Dec 17;65(6):1015-1024. doi: 10.1042/EBC20210038. Essays Biochem. 2021. PMID: 34414429 Free PMC article. Review.

3

The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn's Disease.

Suau R, Pardina E, Domènech E, Lorén V, Manyé J. Suau R, et al. J Crohns Colitis. 2022 Mar 14;16(3):472-489. doi: 10.1093/ecco-jcc/jjab159. J Crohns Colitis. 2022. PMID: 34528668

4

Bile acids and their receptors in regulation of gut health and diseases.

Lin S, Wang S, Wang P, Tang C, Wang Z, Chen L, Luo G, Chen H, Liu Y, Feng B, Wu D, Burrin DG, Fang Z. Lin S, et al. Prog Lipid Res. 2023 Jan;89:101210. doi: 10.1016/j.plipres.2022.101210. Epub 2022 Dec 25. Prog Lipid Res. 2023. PMID: 36577494 Review.

5

The interplay between bile acids and mucosal adaptive immunity.

Mohammed AD, Ball RAW, Kubinak JL. Mohammed AD, et al. PLoS Pathog. 2023 Jun 22;19(6):e1011356. doi: 10.1371/journal.ppat.1011356. eCollection 2023 Jun. PLoS Pathog. 2023. PMID: 37347728 Free PMC article. No abstract available.

6

Bile acid-gut microbiota crosstalk in irritable bowel syndrome.

Gu Y, Li L, Yang M, Liu T, Song X, Qin X, Xu X, Liu J, Wang B, Cao H. Gu Y, et al. Crit Rev Microbiol. 2023 May;49(3):350-369. doi: 10.1080/1040841X.2022.2058353. Epub 2022 Apr 7. Crit Rev Microbiol. 2023. PMID: 35389754 Review.

7

T_H17 cell heterogeneity and its role in tissue inflammation.

Schnell A, Littman DR, Kuchroo VK. Schnell A, et al. Nat Immunol. 2023 Jan;24(1):19-29. doi: 10.1038/s41590-022-01387-9. Epub 2023 Jan 3. Nat Immunol. 2023. PMID: 36596896 Review.

8

Targeting Th17 cells in HIV-1 remission/cure interventions.

Fert A, Raymond Marchand L, Wiche Salinas TR, Ancuta P. Fert A, et al. Trends Immunol. 2022 Jul;43(7):580-594. doi: 10.1016/j.it.2022.04.013. Epub 2022 May 31. Trends Immunol. 2022. PMID: 35659433 Review.

9

A self-amplified ROS-responsive chemodrug-inhibitor conjugate for multi-drug resistance tumor therapy.

Sun T, Xu J, Chen T, Tu C, Zhu L, Yan D. Sun T, et al. Biomater Sci. 2022 Feb 15;10(4):997-1007. doi: 10.1039/d1bm01605a. Biomater Sci. 2022. PMID: 35044379

10

Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases.

Kayama H, Takeda K. Kayama H, et al. Eur J Immunol. 2023 Aug;53(8):e2249866. doi: 10.1002/eji.202249866. Epub 2023 May 24. Eur J Immunol. 2023. PMID: 37191284 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year